Kobayashi Mariko, Arase Yasuji, Ikeda Kenji, Tsubota Akihito, Suzuki Yoshiyuki, Hosaka Tetsuya, Saitoh Satoshi, Kobayashi Masahiro, Suzuki Fumitaka, Akuta Norio, Someya Takashi, Matsuda Marie, Sato Junko, Kumada Hiromitsu
Research Institute for Hepatology, Toranomon Hospital, 1-3-1 Kajigaya, Takatsu-ku, Kawasaki 213-8587, Japan.
J Gastroenterol. 2003;38(7):656-62. doi: 10.1007/s00535-003-1118-7.
Hepatitis B virus (HBV) genotype A is predominant in northern Europe and central Africa. In the present study, we examined the clinical features associated with HBV genotype A disease in the Tokyo metropolitan area.
We investigated 53 cases of HBV surface antigen (HBsAg)-positive Japanese patients with HBV genotype A. The 53 cases were further classified as to their serum alanine aminotransferase (ALT) status being within the normal range (asymptomatic carriers, n = 17), chronic hepatitis (n = 15), liver cirrhosis (n = 4), and acute hepatitis (n = 17).
Chronic hepatitis patients had significantly higher HBV DNA levels (P = 0.003) and hepatitis B e antigen (HBeAg) positivity rates at the initial visit than did asymptomatic carriers or patients with liver cirrhosis (P = 0.003 and P = 0.054, respectively). The efficacy of treatment (HBeAg seroconversion rate) was 75% in 12 chronic hepatitis patients, which was excellent. A family history of HBsAg positivity was identified in eight (15%) families (five asymptomatic carriers, three with chronic hepatitis). However, none of the mothers in the study was positive for HBV genotype A.
Maternal transmission of HBV has often been reported in Japan, but our present findings suggest that horizontal infection of HBV genotype A is more prevalent in the Tokyo metropolitan area. Our data indicate that HBV genotype A exhibits a mode of infection different from that of conventional HBV previously seen in Japan.
乙型肝炎病毒(HBV)A基因型在北欧和中非占主导地位。在本研究中,我们调查了东京都市区与HBV A基因型疾病相关的临床特征。
我们调查了53例HBV表面抗原(HBsAg)阳性的日本HBV A基因型患者。这53例患者根据血清丙氨酸氨基转移酶(ALT)状态进一步分类为正常范围(无症状携带者,n = 17)、慢性肝炎(n = 15)、肝硬化(n = 4)和急性肝炎(n = 17)。
慢性肝炎患者初次就诊时的HBV DNA水平显著高于无症状携带者或肝硬化患者(P = 0.003),乙肝e抗原(HBeAg)阳性率也显著高于无症状携带者或肝硬化患者(分别为P = 0.003和P = 0.054)。12例慢性肝炎患者的治疗效果(HBeAg血清学转换率)为75%,效果良好。在8个(15%)家庭中发现有HBsAg阳性家族史(5例无症状携带者,3例慢性肝炎患者)。然而,本研究中的母亲均无HBV A基因型阳性。
在日本,HBV母婴传播屡有报道,但我们目前的研究结果表明,HBV A基因型的水平感染在东京都市区更为普遍。我们的数据表明,HBV A基因型表现出与日本以前所见的传统HBV不同的感染模式。